BioSpace News Archive

Discovery of biomarker evidence in Castleman Disease exemplifies the value of personalized medicine in rare diseases

Fixed-Dose Combination HIV Treatment Backbone Can Be Paired with Range of Third Agents

Slide Deck and transcript available for download

Gilead Sciences, Inc. (NASDAQ: GILD) announced today that the National Medical Products Administration (NMPA) has approved Harvoni® (ledipasvir 90 mg/sofosbuvir 400 mg) in China for the treatment of chronic hepatitis C virus (HCV) genotype 1-6 infection in adults and adolescents aged 12 to 18 years.

Cerebain Biotech Corp. today announced that it has initiated a repositioning and review of its overall business and corporate strategic plan to maximize shareholder value.

Maiysha Clairborne, M.D. Launches First Entrepreneur’s Institute for Physicians

Biennial event advances RiverWoods’ growing mission to give back, with record-breaking donations

Olea Sensor Networks, a leader in intelligent sensors and analytic software for sensor network-based systems, announced their next gen OleaSenseTM OS-3010 development platform for IoT applications featuring a new design made compatible with Raspberry Pi as well as all Linux and Android based systems.

Jennifer Walden, MD, board certified by the American Board of Plastic Surgery and Secretary of the American Society for Aesthetic Plastic Surgery, recently purchased Skintology Medspa and that location and staff are now certified and equipped to administer Big D Wave® treatments for erectile dysfunction (ED) for men.

KATOR, a start-up medical device company focused on advanced tissue-to-bone reattachment systems, announced today that the United States Patent and Trademark Office has recently granted the company a key patent related to its innovative suture anchor technology.